San Diego, CA, United States of America

Retrophin, Inc.


USPTO Granted Patents = 8

% Expired Patents = 87.5


Trademarks = 9

Forward Citations = 12

Loading Chart...
Loading Chart...

18 inventors (with patents filed for the assignee):

goldMedal Andrew Vaino (5 out of 7 patents)

silverMedal Marek Biestek (5 out of 5 patents)

bronzeMedal Martin Shkreli (5 out of 5 patents)

4.  Henry R Costantino (1 out of 91 patents)

5.  Daniel Elbaum (1 out of 40 patents)

6.  Joshua Sestak (1 out of 3 patents)

7.  Radko Komers (1 out of 3 patents)

8.  Alvin Shih (1 out of 2 patents)

9.  Savina Malancona (1 out of 5 patents)

10.  Maria Beconi (1 out of 1 patent)

11.  Steven Harper (1 out of 16 patents)

12.  Anthony P Sileno (1 out of 18 patents)

13.  Steven C Quay (1 out of 94 patents)

14.  Alexis Kays Leonard (1 out of 1 patent)

15.  Lalit Raj Peddakota (1 out of 1 patent)


8 patents:

Retrophin, Inc. is a biopharmaceutical company focused on the development, acquisition and commercialization of therapies for the treatment of rare diseases. They aim to bring life-changing therapies to people living with rare diseases, with a commitment to improving the lives of patients and their families.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

8 Patents

#635 in San Diego, CA

#8,523 in California

#35,846 in US

San Diego, CA (US)
San Diego, CA, United States of America
Forward Citations = 12

18 inventors:

Please report any incorrect information to [email protected]
Loading…